Clinical trials in ovarian cancer, Part 2

被引：0
作者：
Trimble, EL
Schoenfeldt, M
Cornelison, TL
Wright, J
Kolker, A
Christian, M
机构：
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1660 / +
页数：6
相关论文
共 50 条
  • [31] Status of surgical trials in clinical oncology, part 2
    Zacherl, J
    Jakesz, R
    CHIRURG, 2000, 71 (06): : 658 - 666
  • [32] Ovarian Cancer The Role of Functional Imaging as an End Point in Clinical Trials
    Sala, Evis
    DeSouza, Nandita
    Lee, Susanna I.
    Atri, Mostafa
    Hricak, Hedvig
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 971 - 978
  • [33] Clinical trials in patients with epithelial ovarian cancer: Past, present and future
    Vermorken, JB
    Pecorelli, S
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (05): : 455 - 466
  • [34] Clinical Trials in Elderly Ovarian Cancer Patients - Does It Make Sense?
    Kuhn, Walther
    ONKOLOGIE, 2012, 35 (03): : 73 - 74
  • [35] Ovarian cancer clinical trials: Study the studies to terminate the terminations.
    Spinosa, Daniel
    Howell, Elizabeth
    Williams, D'Erryl
    Watson, Catherine
    Akinyemiju, Tomi F.
    Previs, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] What are the barriers to assessment of ovarian toxicity in breast cancer clinical trials?
    Cui, Wanyuan
    Phillips, Kelly-Anne
    Francis, Prudence A.
    Loi, Sherene
    Anderson, Richard A.
    Partridge, Ann H.
    Keogh, Louise A.
    CANCER RESEARCH, 2022, 82 (04)
  • [37] PATIENT-REPORTED OUTCOMES (PROS) IN OVARIAN CANCER CLINICAL TRIALS
    Pease, S.
    Barsdorf, A., I
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [38] ATP chemosensitivity testing in ovarian and breast cancer:: Early clinical trials
    Kurbacher, CM
    Grecu, OM
    Stier, U
    Gilster, TJ
    Janát, MM
    Untch, M
    Konecny, G
    Bruckner, HW
    Cree, IA
    CHEMOSENSITIVITY TESTING IN ONCOLOGY, 2003, 161 : 221 - 230
  • [39] Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?
    Karlan, BY
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 227 - 232
  • [40] Virtual clinical trials identify effective combination therapies in ovarian cancer
    Emilia Kozłowska
    Tuulia Vallius
    Johanna Hynninen
    Sakari Hietanen
    Anniina Färkkilä
    Sampsa Hautaniemi
    Scientific Reports, 9
12345